ISCD Learning
Catalog Advanced Search
-
Includes Multiple Live Events. The next is on 12/06/2025 at 10:00 AM (EST)ASRT Category A Credits
Course Date: December 6 & 7, 2025. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.
Course Date
December 6 & 7, 2025.
Course Description
The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.
Target Audience
The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.
Learning Objectives
After attending the course, participants should be better prepared to:
- Design and implement quality control and assurance practices.
- Perform a precision assessment and appreciate the requirement for clinical care.
- Identify the anatomy relevant to clinical DXA scanning.
- Implement consistent and appropriate technical acquisition and analysis techniques.
- Perform a fracture risk assessment using FRAX.
- Provide DXA interpreters sufficient information for a high-quality DXA report.
- Discuss supplemental software and their application.
- Demonstrate how to access features within the DXA software.
- Understand how specific medical conditions and medications affect bone density.
- Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
- Recognize how technical errors impact clinical interpretation and patient care.
Method of Participation
This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 6 & 7, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.
Registration Fee
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ASRT Credit Designation
This activity has been approved by ASRT for 13.75 Category A Continuing Education credits.
ASRT Credit Notice
This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - December 6, 2025 - All times Eastern (NYC/USA)
Schedule - December 7, 2025 - All times Eastern (NYC/USA)
Diane Krueger, BS, CBDT
Researcher
Osteoporosis Clinical Research Program - University of Wisconsin, Madison
Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.
Greg Yardley
Sr. Medical Radiology Technologist and Researcher
NASA Bone Mineral Laboratory
Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing Dual Energy X-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, and aids in bone density interpretation and distributes bone data from DXA, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) devises. Greg also performs diagnostic medical X-rays for the NASA/JSC Flight medicine and occupational health clinic.
Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered Radiology Technologist. Greg has worked as a Radiology Technologist in a trauma level 1 hospital, level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011, just previous to his current job, Greg worked as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.
Sherri Ford, CBDT
Research Interventionist
Wake Forest University
Sherri Ford has an extensive work history in clinical medicine and research. In her role as a Research Interventionist, she has the opportunity to work with members in a group, as well as one on one, to help them achieve wellness goals. During the past 7 years, she has been involved in several research projects with Wake Forest University. She has also designed and written a bone densitometry curriculum for technologists who are preparing for the certification exam, and she holds dual certifications with the ARRT and ISCD in diagnostic imaging/bone densitometry. She has been performing DXA scans since 1996 and is able to use her DXA experience in her current role as a Research Interventionist. She manages both DXA machines on campus (Wake Forest University) and is responsible for training staff and grad students reviewing scans to ensure proper acquisition and analyzation, especially research study exams.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $400
- Full Member - $300
- MOC Only - $400
- Community Member - $400
- Professional Member - $400
- More Information
-
Includes Multiple Live Events. The next is on 12/06/2025 at 10:00 AM (EST)ACCME Pra Category 1 Credits
Course Date: December 6 & 7, 2025. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.
Course Date
December 6 & 7, 2025.
Course Description
The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.
Target Audience
The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD Quality Bone Densitometry for Technologists Course.
Learning Objectives
After attending the course, participants should be better prepared to:
- Describe appropriate clinical evaluation of patients at risk for fragility fracture.
- Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD.
- Recognize errors in DXA analysis and reporting.
- Explain new and emerging guidelines that provide evidence-based information regarding skeletal health.
- Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.
Method of Participation
This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 6 & 7, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 13.00 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - December 6th, 2025 - All times Eastern Standard Time (NYC/USA)
Schedule - December 7th, 2025 - All times Eastern Standard Time (NYC/USA)
Dr Neil Binkley MD, CCD
Professor
University of Wisconsin Madison
Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.
Steven M. Petak, MD, JD, MACE, FACP
Division Head and Clinical Service Chief Endocrinology
Houston Methodist Hospital
Dr. Steven Petak is a clinical and academic endocrinologist in Houston, Texas.
He is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org). He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor.
His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.
He received his MD from the University of Illinois in Chicago and has his JD from the University of Houston (Magna cum Laude). He had his internship, residency, medical chief residency, and fellowship in endocrinology and metabolism at the University of Texas at Houston. He was at the Texas Institute for Reproductive Medicine and Endocrinology in Houston for about 26 years before joining the academic endocrine group at Methodist in May 2013. He is board certified in internal medicine as well as endocrinology and metabolism.
S. Bobo Tanner, MD, CCD
Director of the Vanderbilt Osteoporosis Clinic
Vanderbilt University Medical Center
S. Bobo Tanner, MD, CCD, is a graduate of Harvard University in Cambridge, Massachusetts, with a BA in History and Science, and received his medical degree with honors from Bowman Gray Medical School of Wake Forest University, Winston-Salem, North Carolina. He pursued his internship and residency at the Vanderbilt University Hospital in Nashville, Tennessee, and completed fellowships and board certification in Rheumatology and in Allergy/Immunology. Dr. Tanner served as a Registrar in the Department of Rheumatology at the Royal Free Hospital, London, England.
Afterwards he returned to Vanderbilt and was Founder and Director of the Vanderbilt Osteoporosis Clinic which is part of the Rheumatology Division.
In 2007 he received the Clinician of the Year Award from International Society for Clinical Densitometry and in 2017 he was recognized with the President’s Award from the Tennessee Rheumatology Society.
His professional membership and service includes the American College of Physicians, Fellow of the American College of Rheumatology, member of the Royal Society of Medicine, and the American Academy of Asthma, Allergy & Immunology, past secretary/ treasurer of the Tennessee Rheumatology Society, past president of the Tennessee Allergy Society and past president of the International Society for Clinical Densitometry. He currently works on the ISCD Education Council where he updates and teaches the CME Bone Density Courses throughout the year. He is a Certified Clinical Densitometrist. His is on the editorial board for the Journal of Clinical Densitometry and Therapeutic Advances in Musculoskeletal Disease.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity.
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties.
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $800
- Full Member - $500
- MOC Only - $800
- Community Member - $800
- Professional Member - $800
- More Information
-
Includes Multiple Live Events. The next is on 10/18/2025 at 10:00 AM (EDT)Both ACCME and ASRT Credits
Course Date: October 18, 2025. The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.
Course Date
October 18, 2025.
Course Description
The Pediatric Bone Densitometry Course provides current research and best-practice techniques for the acquisition and interpretation of bone mineral density (BMD) in children and adolescents. This educational program is designed to improve learner competence in pediatric bone densitometry. By completing this course, attendees will gain conceptual and practical knowledge which can be applied in their professional practices.
Target Audience
The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.
Learning Objectives
After attending the course, participants should be better prepared to:
- Recognize considerations and concerns with skeletal assessment in children and adolescents with a variety of medical conditions.
- Identify the most appropriate and reproducible sites for densitometry in children and adolescents.
- Evaluate technical aspects of bone assessment in children and adolescents.
- Describe the uses of measurement tools for acquiring bone densitometry assessments by DXA and other modalities.
- Summarize the elements to be included in a pediatric DXA report.
Method of Participation
This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on October 18, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation:
This activity is under review for accreditation by ASRT targeting 4.5 Category A Continuing Education credits.
Deadline to Claim Credit:
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - October 18, 2025 - All times eastern (NYC/USA)
Kyla Kent, BA, CBDT
Technical Director
SAMBA Lab, Stanford University School of Medicine
Kyla Kent, BA, CBDT, Technical Director of the SAMBA (Stanford Assessments of Muscle and Bone across the Ages) Lab, has been with Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care system since 1991 in the Stanford Prevention Research Center, the Musculo-Skeletal Research Lab and most recently the SAMBA Lab. Responsibilities include development and technical assessment of research protocols, clinical facility management, supervisor for clinical staff, performance of DXA, HRpQCT, Biodex and other measures related to research conducted in the areas of bone metabolism, structural assessment, body composition, exercise, sleep and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for the Stanford Children’s Hospital, Palo Alto VA Hospital and Stanford Hospital/Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Currently acting in the position of Technical Director for the SAMBA Lab and as consultant developing a program for Quality DXA across all of Stanford’s clinical networks. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD). She also has acted as the Director, clinical instructor and lecturer for a State certified training program for DXA.
Ciara McDonnell, MD, FRCPI
Consultant Paediatrician s.i. Endocrinology & Diabetes
Children's Health Ireland
Dr. McDonnell is a graduate of University of Dublin, Trinity College, Dublin Ireland and completed her postgraduate fellowship in Paediatric Endocrinology & Diabetes at the Royal Children's Hospital in Melbourne, Australia in 2004. She is a Consultant in Paediatric Endocrinology & Diabetes in Children's Health Ireland, Dublin where she has developed a subspecialist interest in bone metabolism, skeletal dysplasias and rare bone disease. She founded the Paediatric Bone Densitometry Service in 2019 and has established a clinical service in Rare Bone Diseases called Our Tribe for children and adolescents in Ireland. She is the paediatric representative on the Irish DXA society, a member of the paediatric committee of the ISCD, secretary of the International Society of Children's Bone Health and paediatric lead for the European Reference Network in Rare Bone Disease (BOND).
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $200
- Full Member - $100
- MOC Only - $200
- Community Member - $200
- Professional Member - $200
- More Information
-
Includes Multiple Live Events. The next is on 10/04/2025 at 10:00 AM (EDT)Both ACCME and ASRT Credits
Course Date: October 4, 2025. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.
Course Date
October 4, 2025, 10am-2pm ET
Course Description
This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.
Target Audience
The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.
Learning Objectives
After attending the course, participants should be better prepared to:
- Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
- List other methods of body composition analysis used in the clinical setting.
- Differentiate reference values and indices.
- Identify limitations of reference values and indices.
- Summarize scan acquisition for adult and pediatric patients.
Method of Participation
This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on October 4, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation:
This activity is under review for accreditation by ASRT targeting 4.5 Category A Continuing Education credits.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule October 4, 2025 - All times eastern (NYC/USA)
Greg Yardley
Sr. Medical Radiology Technologist and Researcher
NASA Bone Mineral Laboratory
Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing Dual Energy X-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, and aids in bone density interpretation and distributes bone data from DXA, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) devises. Greg also performs diagnostic medical X-rays for the NASA/JSC Flight medicine and occupational health clinic.
Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered Radiology Technologist. Greg has worked as a Radiology Technologist in a trauma level 1 hospital, level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011, just previous to his current job, Greg worked as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.
John A. Shepherd, PhD, CCD
Professor/Chief Scientific Officer
University of Hawaii Cancer Center, Honolulu, HI
Dr. Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar, a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a former President of the International Society for Clinical Densitometry. He received his PhD in Engineering Physics from the University of Virginia and then completed a Postdoctoral Fellowship in Biophysics at Princeton University. From there he went on to develop body composition and bone density algorithms for a major women’s health company and his patents are the basis for the accuracy of that company’s body composition algorithms. He then joined the Radiology Department of the University of California San Francisco and led his own research group for 19 years studying a wide variety of biomarkers for breast cancer, obesity and osteoporosis from medical imaging using advanced machine learning techniques. For the past 5 years, he has been with the University of Hawaii Cancer Center and is currently their Chief Scientific Officer. He also directs the UH Artificial Intelligence Precision Health Institute and the Hawaii Pacific Islands Mammography Registry. He has been continuously funded from the NIH since 2005, led 6 R01-funded studies, published over 350 peer-review publications that have been referenced over 23,000 times, and lastly is an avid surfer and island ridge hiker!
Statement of independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $200
- Full Member - $100
- MOC Only - $200
- Community Member - $200
- Professional Member - $200
- More Information
-
Includes Multiple Live Events. The next is on 09/20/2025 at 10:00 AM (EDT)ASRT Category A Credits
Course Date: September 20 & 21, 2025. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.
Course Date
September 20 & 21, 2025.
Course Description
The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.
Target Audience
The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.
Learning Objectives
After attending the course, participants should be better prepared to:
- Design and implement quality control and assurance practices.
- Perform a precision assessment and appreciate the requirement for clinical care.
- Identify the anatomy relevant to clinical DXA scanning.
- Implement consistent and appropriate technical acquisition and analysis techniques.
- Perform a fracture risk assessment using FRAX.
- Provide DXA interpreters sufficient information for a high-quality DXA report.
- Discuss supplemental software and their application.
- Demonstrate how to access features within the DXA software.
- Understand how specific medical conditions and medications affect bone density.
- Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
- Recognize how technical errors impact clinical interpretation and patient care.
Method of Participation
This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on September 20 & 21, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.
Registration Fee
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ASRT Credit Designation
This activity has been approved by ASRT for 13.75 Category A Continuing Education credits.
ASRT Credit Notice
This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - September 20, 2025 - All times Eastern (NYC/USA)
Schedule - September 21, 2025 - All times Eastern (NYC/USA)
Anita Colquhoun, RTNM, MRT(N), CDT
Charge Technologist
Women's College Hospital
Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.
Greg Yardley
Sr. Medical Radiology Technologist and Researcher
NASA Bone Mineral Laboratory
Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing Dual Energy X-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, and aids in bone density interpretation and distributes bone data from DXA, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) devises. Greg also performs diagnostic medical X-rays for the NASA/JSC Flight medicine and occupational health clinic.
Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered Radiology Technologist. Greg has worked as a Radiology Technologist in a trauma level 1 hospital, level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011, just previous to his current job, Greg worked as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.
John Monk, RT(R)(QM)(BD), CBDT
DXA Specialist
M Health Fairview | Imaging Service Line
John is the DXA specialist at Fairview Health Services, a healthcare provider based in Minneapolis but serves most parts of Minnesota. John began his career performing scans on a Lunar (now GE Lunar) in 1996. He became certified as a CDT through the International Society for Clinical Densitometry (ISCD) in 1997, then became a CBDT in 2008. John was an adjunct instructor for the Minnesota State College and University System, teaching Bone Densitometry 1 and 2 from 2003 to 2011 to imaging students. John has performed scans on all GE Lunar models. John was also an item writer and cognitive objective writer for the first national exam in Bone Densitometry through the American Registry of Radiologic Technologists (ARRT) in 2001.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $400
- Full Member - $300
- MOC Only - $400
- Community Member - $400
- Professional Member - $400
- More Information
-
Includes Multiple Live Events. The next is on 09/20/2025 at 10:00 AM (EDT)ACCME Pra Category 1 Credits
Course Date: September 20 & 21, 2025. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.
Course Date
September 20 & 21, 2025.
Course Description
The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.
Target Audience
The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD Quality Bone Densitometry for Technologists course.
Learning Objectives
After attending the course, participants should be better prepared to:
- Describe appropriate clinical evaluation of patients at risk for fragility fracture.
- Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD.
- Recognize errors in DXA analysis and reporting.
- Explain new and emerging guidelines that provide evidence-based information regarding skeletal health.
- Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.
Method of Participation
This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 20 & 21, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 13.00 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Deadline to Claim Credit
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - Sept 20th, 2025 - All times Eastern Standard Time (NYC/USA)
Schedule - Sept 21st, 2025 - All times Eastern Standard Time (NYC/USA)
Christopher Shuhart, MD, MHA, CCD
Director of the Bone Health and Osteoporosis Center
Swedish Medical Group
Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) from 2019-2020, with multiple years in Executive and Board of Directors roles, and has served on numerous ISCD committees and task forces. He received ISCD's Paul Miller Service Award in 2022.
He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was the Organizing Chair for the 2019 ISCD Position Development Conference (PDC) in Kuala Lumpur, Malaysia, as well as lead author of the 2019 PDC Executive Summary. He is the Administrative Chair for the 2023 PDC.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.
S. Bobo Tanner, MD, CCD
Director of the Vanderbilt Osteoporosis Clinic
Vanderbilt University Medical Center
S. Bobo Tanner, MD, CCD, is a graduate of Harvard University in Cambridge, Massachusetts, with a BA in History and Science, and received his medical degree with honors from Bowman Gray Medical School of Wake Forest University, Winston-Salem, North Carolina. He pursued his internship and residency at the Vanderbilt University Hospital in Nashville, Tennessee, and completed fellowships and board certification in Rheumatology and in Allergy/Immunology. Dr. Tanner served as a Registrar in the Department of Rheumatology at the Royal Free Hospital, London, England.
Afterwards he returned to Vanderbilt and was Founder and Director of the Vanderbilt Osteoporosis Clinic which is part of the Rheumatology Division.
In 2007 he received the Clinician of the Year Award from International Society for Clinical Densitometry and in 2017 he was recognized with the President’s Award from the Tennessee Rheumatology Society.
His professional membership and service includes the American College of Physicians, Fellow of the American College of Rheumatology, member of the Royal Society of Medicine, and the American Academy of Asthma, Allergy & Immunology, past secretary/ treasurer of the Tennessee Rheumatology Society, past president of the Tennessee Allergy Society and past president of the International Society for Clinical Densitometry. He currently works on the ISCD Education Council where he updates and teaches the CME Bone Density Courses throughout the year. He is a Certified Clinical Densitometrist. His is on the editorial board for the Journal of Clinical Densitometry and Therapeutic Advances in Musculoskeletal Disease.
Gillian Wooldridge, DO, CCD
Gillian Wooldridge is a primary care sports medicine physician in Houston, Texas. She completed her undergraduate studies in Kinesiology-Sports Medicine at Rice University in 2009. She received her medical degree from the Texas College of Osteopathic Medicine in 2014, where she was the inaugural recipient of the Sports Medicine Achievement Award. Dr Wooldridge completed her family medicine residency in 2017 and sports medicine fellowship in 2018, with Houston Methodist and Houston Methodist Willowbrook Hospitals respectively.
She currently works for Houston Methodist Orthopedics and Sports Medicine in the Texas Medical Center. She serves as a team physician for Rice University Athletics and volunteers with several organizations in the community including the Chevron Houston Marathon, IronMan Texas and the Houston Livestock Show and Rodeo. Dr Wooldridge is a member of the board of directors for the American Osteopathic Academy of Sports Medicine and is actively involved in the American Medical Society of Sports Medicine as an item writer for the sports medicine in-training exam.
She is a certified clinical densitometrist and works on the Osteoporosis Essentials Course Committee and serves as a co-director of the Bone Health Initiative in the Houston Methodist Orthopedics and Sports Medicine department. She holds a core clinical faculty position with the Texas A&M College of Medicine Engineering & Medicine program and a clinical faculty position the Tillman Fertitta Family College of Medicine.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity.
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties.
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $800
- Full Member - $500
- MOC Only - $800
- Community Member - $800
- Professional Member - $800
- More Information
-
Includes Multiple Live Events. The next is on 09/09/2025 at 7:00 PM (EDT)ACCME Pra Category 1 Credits
Course Date: September 9 & 16, 2025. This ISCD Orthopedic Densitometry Course is a live activity consisting of a variety of sessions in didactic lecture, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice. Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.
Course Date
September 9 & 16, 2025.
Course Description
This ISCD Orthopedic Densitometry Course is a live activity consisting of a variety of sessions in didactic lecture, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice. Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.
This activity was developed with the support of an educational donation provided by Amgen.
Target Audience
The ISCD Orthopedic Densitometry Course is designed for healthcare professionals with an interest in orthopedics, osteoporosis, and bone health across the lifespan, including those working in orthopedics, radiology and diagnostic imaging, physical and occupational therapy, public health, and research. These include physicians, nurses, nurse practitioners, physician assistants, radiology technologists, physical therapists, and occupational therapists.
Osteoporosis is a common problem that causes your bones to become abnormally thin, weakened, and easily broken (fractured). Fortunately, preventive treatments are available that can help to maintain or increase bone density. If osteoporosis has been diagnosed, therapies are available that can slow further loss of bone or increase bone density. The trend of under-diagnosis and treatment of osteoporosis continues to occur despite the fact that effective therapy exists to reduce future fractures. This gap in treatment and diagnosis of osteoporosis could lead to an epidemic of new fractures. Clinicians and healthcare professionals must be familiar with and aware of new and current therapeutic agents to treat fracture risk and osteoporosis. They must know how to initiate proper treatment based on clinical assessment and published guidelines. The dissemination of evidence-based information on the balance of benefit and risk could help to reduce the treatment gap and improve patient health. Clinicians and other members of the healthcare team may be unfamiliar with the WHO’s definition of osteoporosis, understand the presence of fragility fracture warrants pharmacological intervention and the role of FRAX in the treatment intervention of osteoporosis.
Learning Objectives
After attending the course, participants should be better prepared to:
- Understand various pharmacological treatments available and treatment algorithms.
- Understand and implement the recommendation of the four “pillars”.
- Describe the principles of using DXA as a monitoring tool and understand which densitometric method to use.
Method of Participation
This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on September 9 & 16, 2025. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
This live activity is under review for accreditation by Amedco LLC targeting a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Deadline to Claim Credit:
Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit.
Schedule - September 9 & 16, 2025, 7pm - 9pm EST
Paul A. Anderson, MD, MS
Emeritus Professor of Orthopedics
University of Wisconsin
Dr. Anderson is a board-certified orthopaedic spine surgeon with special interest in spine trauma, tumors, cervical spine, and geriatric spinal diseases and osteoporosis. He is an internationally recognized expert in the field of orthopaedic spinal surgery and currently holds an academic position as Emeritus Professor of Orthopedics at the University of Wisconsin. He has served as President of the Cervical Spine Research Society and President of the Lumbar Spine Research Society and has held various positions in a number of spinal and orthopaedic societies. He has served as a member as well as Chairman of the AAOS Biomedical Engineering Committee, Co-Chair of ASTM 04.25, and Clinical Chair of ASTM F04. Most recently, he chaired the “Own the Bone” Steering Committee of the American Orthopaedic Association which aims to educate medical practitioners and patients on the importance of bone health and promote fracture liaison services. In 2022 he received the 3rd Annual Lifetime Achievement Award from the Cervical Spine Research Society. He currently serves as a Reviewer for Osteoporosis International and a member of the Scientific Advisory Council of ISCD as well as Vice President of ISCD. Dr. Anderson earned his undergraduate and Master’s degrees from The University of Michigan in Chemical Engineering. He completed medical school and orthopaedic residency at Wayne State University and a clinical spine fellowship with Dr. Henry H. Bohlman (Case Western Reserve University, Cleveland).
Kristyn J. Hare, MMS, PA-C, CCD
University of Wisconsin Orthopedic Bone Health
Ms. Hare is a certified physician assistant and clinical densitometrist with special interest in bone health and treatment of osteoporosis. She has over 17 years of experience as a PA in Orthopedics including previous roles in pain management, interventional pain and non operative spine care. She has played a leading role in establishing the University of Wisconsin Orthopedics Bone Health clinic including the Fracture Liaison Service (FLS) and Bone Health Optimization (BHO) programs over the last 8 years. She is the 2024 American Orthopedic Association Andrew Bunta clinician of the year. She has participated in preparing several publications in the field of Orthopedic Bone Health and has presented on the topic to several different organizations with a focus on helping advanced practice providers develop similar bone health programs. Ms. Hare earned her undergraduate degree from the University of Wisconsin in Biochemistry. She completed her Master’s degree in Physician Assistant studies at Midwestern University (Downers Grove, IL).
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
-
Register
- Non-Member - $200
- Full Member - $100
- MOC Only - $200
- Community Member - $200
- Professional Member - $200
- More Information
-
ACCME Pra Category 1 Credits
Expires May 7, 2026: This session will discuss the value of opportunistic CT in a bone health practice and will demonstrate how to use opportunistic CT to screen for low bone density and vertebral fractures.
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™
Activity is not accredited for ASRT credits.
This activity expires May 7, 2026.Activity Description
This session will discuss the value of opportunistic CT in a bone health practice and will demonstrate how to use opportunistic CT to screen for low bone density and vertebral fractures.
Learning Objectives
- Define opportunistic CT
- Apply opportunistic CT to screen for low bone density and vertebral fractures
- Discuss how to perform opportunistic CT in clinical practice
Instructions
Attend the live airing and/or view the recording of the webinar. After, you will be asked to evaluate the activity online and then be allowed to claim credit and print your certificate.
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration Fees
Cancellation Policy
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
Kristyn J. Hare, MMS, PA-C, CCD
University of Wisconsin Orthopedic Bone Health
Ms. Hare is a certified physician assistant and clinical densitometrist with special interest in bone health and treatment of osteoporosis. She has over 17 years of experience as a PA in Orthopedics including previous roles in pain management, interventional pain and non operative spine care. She has played a leading role in establishing the University of Wisconsin Orthopedics Bone Health clinic including the Fracture Liaison Service (FLS) and Bone Health Optimization (BHO) programs over the last 8 years. She is the 2024 American Orthopedic Association Andrew Bunta clinician of the year. She has participated in preparing several publications in the field of Orthopedic Bone Health and has presented on the topic to several different organizations with a focus on helping advanced practice providers develop similar bone health programs. Ms. Hare earned her undergraduate degree from the University of Wisconsin in Biochemistry. She completed her Master’s degree in Physician Assistant studies at Midwestern University (Downers Grove, IL).
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $50
- Full Member - Free!
- MOC Only - $50
- Community Member - $50
- Professional Member - $25
- More Information
-
Both ACCME and ASRT Credits
Expires 11/14/2025: Serial and combination treatment in osteoporosis.
Activity approved for 1.5 ASRT Category A Credits
Activity approved for up to 1 AMA PRA Category 1 Credits™
Activity Expires November 14, 2025Activity Description
Serial and combination treatment in osteoporosis.
Learning Objectives:
- Explain the objectives in osteoporosis treatment and differentiate between approved pharmacologic agents.
- Describe the importance of sequencing osteoporosis treatments.
- Explain the justification for using osteoanabolic agents as initial treatment for osteoporosis.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on November 15, 2024.
Andrea J. Singer, MD, FACP CCD
Director of Women’s Primary Care, Director of the Bone Densitometry Program, and Medical Director of the Fracture Liaison Service
MedStar Georgetown University Hospital in Washington, DC
Andrea J. Singer, MD, FACP CCD, is Director of Women’s Primary Care, Director of the Bone Densitometry Program, and Medical Director of the Fracture Liaison Service focusing on secondary fracture prevention at MedStar Georgetown University Hospital in Washington, DC. She holds a dual appointment in the Departments of Medicine and Obstetrics at Gynecology at Georgetown University Medical Center, Washington, DC. Dr. Singer earned her medical degree at Albert Einstein College of Medicine in Bronx, NY. She completed her internship and residency, including serving as Chief Resident, at Georgetown University Medical Center in Washington, DC. Dr. Singer is Chief Medical Officer at the Bone Health and Osteoporosis Foundation (formerly the National Osteoporosis Foundation) and has been a member of the Board of Trustees. She co-chairs the annual Interdisciplinary Symposium on Osteoporosis for BHOF. Dr Singer has been the principal investigator for several clinical trials and quality improvement projects in osteoporosis and bone health. Her areas of interest include women’s health, osteoporosis management, economic impact of osteoporosis, secondary fracture prevention, menopause, and sexual health, and she has authored numerous publications in in peer-reviewed journals including Mayo Clinic Proceedings, Osteoporosis International, Journal of Bone and Mineral Research, Current Medical Research Opinion, and Journal of Bone and Joint Surgery, among others, as well as book chapters and online publications. She is Section Editor for Bone Health in Journal of Women’s Health, a member of the Editorial Board of Osteoporosis: Clinical Updates, and Reviewer for Osteoporosis International, American Journal of Obstetrics and Gynecology, and Journal of Sexual Medicine.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $25
- Full Member - Free!
- MOC Only - Free!
- Community Member - $25
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2025: This talk will review the clinical presentation, diagnosis, and management of hypophosphatasia in a case-based format.
Activity approved for 1.5 ASRT Category A Credits
Activity approved for up to 1.00 AMA PRA Category 1 Credits™
Activity Expires October 14, 2025Activity Description
This talk will review the clinical presentation, diagnosis, and management of hypophosphatasia in a case-based format.
Learning Objectives:
- Establish an approach to thinking about hypophosphatasia (HPP) and when you should be concerned about this disease in patients.
- Learn the different clinical manifestations of HPP in adults.
- Discuss diagnosis and management of HPP.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2024.
Chad Deal, MD
Rheumatologist, Head of the Center for Osteoporosis and Metabolic Bone Disease
Cleveland Clinic, Rheumatologic and Immunologic Disease
Chad Deal, MD, is Head of the Center for Osteoporosis and Metabolic Bone Disease and a board-certified Rheumatologist at Cleveland Clinic. He has specialty interests in osteoporosis and related conditions. Dr. Deal did his undergraduate work at Washington University, St. Louis, Mo. He attended medical school at the University of Arkansas, was inducted into Alpha Omega Alpha, and graduated in 1977. His internship and residency were at Boston City Hospital in Boston, Mass. He completed a fellowship in arthritis and connective tissue diseases at Boston University School of Medicine in 1982.
Dr. Deal has been in Cleveland since 1984. He was Associate Professor of Medicine at the Case Western Reserve University School of Medicine until 1999, when he left to become Head of the Center for Osteoporosis and Metabolic Bone Disease at Cleveland Clinic.
Dr. Deal has been an active investigator in multiple clinical trials relating to arthritis and osteoporosis. He has been an investigator in numerous multicenter trials, including drug trials using teriparatide (PTH) with raloxifene, zoledronic acid after teriparatide, and novel anabolic agents. He is author of over 50 publications.
He is a past member on the Committees on Rheumatologic Care, Training and Workforce, and Finance for the American College of Rheumatology. He is currently on the Board of Directors of the American College of Rheumatology. He is a member of the Interspecialty Medical Council of the NOF for the ACR. Dr. Deal is a reviewer for numerous rheumatology, orthopedic and osteoporosis journals. He has received the National Volunteer Service Citation from the Arthritis Foundation, and has been awarded Teacher of the Year in Rheumatic Diseases at Cleveland Clinic. He has been named one of the best doctors in Cleveland.
Learn from Dr. Deal on how osteoporosis, the ‘silent thief of bone,’ can be prevented, detected and treated. Both men and women get osteoporosis and it's a common misconception that only women have osteoporosis.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $25
- Full Member - Free!
- MOC Only - Free!
- Community Member - $25
- Professional Member - Free!
- More Information
